MediWound (MDWD) Cash from Financing Activities (2013 - 2026)
MediWound (MDWD) posted quarterly Cash from Financing Activities of -$1.1 million for Q4 2025, down 112.87% year-over-year from $8.5 million in Q4 2024, and down 103.58% quarter-over-quarter from $30.5 million in Q3 2025.
MediWound (MDWD) Cash from Financing Activities (2013 - 2026) Analysis & Trends
MediWound's Cash from Financing Activities history runs 13 years deep, the most recent figure standing at -$1.1 million for Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 112.87% year-over-year to -$1.1 million; the TTM figure through Dec 2025 stood at $29.6 million (up 52.73% YoY), while the FY2025 annual figure was $29.6 million, up 52.73% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at -$1.1 million, down from $30.5 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $30.5 million in Q3 2025, with the low at -$1.1 million in Q4 2025.
- The 5-year median for Cash from Financing Activities is -$177000.0 (2021), against an average of $5.4 million.
- Peak annual rise in Cash from Financing Activities reached 4554.42% in 2021, while the deepest fall reached 808.0% in 2021.
- MediWound's Cash from Financing Activities stood at -$177000.0 in 2021, then sank by 311.3% to -$728000.0 in 2022, then surged by 71.98% to -$204000.0 in 2023, then slumped by 151.47% to -$513000.0 in 2024, then tumbled by 112.87% to -$1.1 million in 2025.
- Business Quant data shows MDWD's Cash from Financing Activities at -$1.1 million in Q4 2025, $30.5 million in Q3 2025, and $549000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -6.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 36.24 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -16.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 27.18 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -273.15 Mn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | 402,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 402,000.00 |
| Jun 30, 2026 | 402,000.00 |
| Dec 31, 2025 | -1.09 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Sep 30, 2025 | 30.53 Mn |
| Sep 30, 2025 | 30.53 Mn |
| Jun 30, 2025 | 549,000.00 |
| Jun 30, 2025 | 549,000.00 |
| Mar 31, 2025 | -362,000.00 |
| Mar 31, 2025 | -362,000.00 |
| Dec 31, 2024 | -513,000.00 |
| Dec 31, 2024 | -513,000.00 |
| Sep 30, 2024 | 20.71 Mn |
| Sep 30, 2024 | 20.71 Mn |
| Jun 30, 2024 | -103,000.00 |
| Jun 30, 2024 | -103,000.00 |
| Mar 31, 2024 | -699,000.00 |
| Mar 31, 2024 | -699,000.00 |
| Dec 31, 2023 | -204,000.00 |
| Dec 31, 2023 | -204,000.00 |